Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

The volumes provide comprehensive guidance on aesthetic and reconstructive head and neck surgery.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

A new compound was made to detect copper ions effectively.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Keyora Lycopene 23 in 1 Man's Multi-Vitamin improves male reproductive health and metabolism.

Keyora Lycopene 23 in 1 multi-vitamin improves men's reproductive and metabolic health.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Guselkumab significantly improves psoriasis symptoms within 12 weeks.

Compound 7p shows strong potential as an anticancer agent.

Cancer prevention has advanced significantly, with some strategies proving successful.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

A new method using NBD-CL can accurately and precisely measure finasteride in medicine, and could be used regularly for quality control in the industry.

A new compound shows promise as a topical treatment for hair loss.

Calanthoside may help hair growth by boosting cell proliferation.

CaBP1 and CaBP2 are important for maintaining hearing by supporting continuous calcium currents and nerve signaling in the ear.

EGCG shows strong electron transfer interactions when bonded to DPPG lipids.

A new genetic area linked to a rare hair loss condition was found on chromosome 13 in a Chinese family.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

The 11th AICPE Congress in Rimini was a major event in European aesthetic plastic surgery.

The compound 4c showed strong potential as an anticancer agent.

A woman with a unique syndrome similar to TRPS has a genetic change near the TRPS1 gene, affecting its regulation.